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Abstract
Background
Macrolide is the drug of choice to treat human campylobacteriosis, but Campylobacter resistance to this
antibiotic is rising. The mechanisms employed by Campylobacter jejuni to adapt to erythromycin treatment
remain unknown and are examined in this study. The transcriptomic response of C. jejuni NCTC 11168 to
erythromycin (Ery) treatment was determined by competitive microarray hybridizations. Representative
genes identified to be differentially expressed were further characterized by constructing mutants and
assessing their involvement in antimicrobial susceptibility, oxidative stress tolerance, and chicken
colonization.
Results
Following the treatment with an inhibitory dose of Ery, 139 genes were up-regulated and 119 were down-
regulated. Many genes associated with flagellar biosynthesis and motility was up-regulated, while many genes
involved in tricarboxylic acid cycle, electron transport, and ribonucleotide biosynthesis were down-regulated.
Exposure to a sub-inhibitory dose of Ery resulted in differential expression of much fewer genes. Interestingly,
two putative drug efflux operons (cj0309c-cj0310c and cj1173-cj1174) were up-regulated. Although
mutation of the two operons did not alter the susceptibility of C. jejuni to antimicrobials, it reduced
Campylobacter growth under high-level oxygen. Another notable finding is the consistent up-regulation of
cj1169c-cj1170c, of which cj1170c encodes a known phosphokinase, an important regulatory protein in C.
jejuni. Mutation of the cj1169c-cj1170c rendered C. jejuni less tolerant to atmospheric oxygen and reduced
Campylobacter colonization and transmission in chickens.
Conclusions
These findings indicate that Ery treatment elicits a range of changes in C. jejuni transcriptome and affects the
expression of genes important for in vitro and in vivo adaptation. Up-regulation of motility and down-
regulation of energy metabolism likely facilitate Campylobacter to survive during Ery treatment. These
findings provide new insight into Campylobacter adaptive response to antibiotic treatment and may help to
understand the mechanisms underlying antibiotic resistance development.
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to erythromycin treatment
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and Qijing Zhang2*
Abstract
Background: Macrolide is the drug of choice to treat human campylobacteriosis, but Campylobacter resistance to
this antibiotic is rising. The mechanisms employed by Campylobacter jejuni to adapt to erythromycin treatment
remain unknown and are examined in this study. The transcriptomic response of C. jejuni NCTC 11168 to
erythromycin (Ery) treatment was determined by competitive microarray hybridizations. Representative genes
identified to be differentially expressed were further characterized by constructing mutants and assessing their
involvement in antimicrobial susceptibility, oxidative stress tolerance, and chicken colonization.
Results: Following the treatment with an inhibitory dose of Ery, 139 genes were up-regulated and 119 were
down-regulated. Many genes associated with flagellar biosynthesis and motility was up-regulated, while many genes
involved in tricarboxylic acid cycle, electron transport, and ribonucleotide biosynthesis were down-regulated. Exposure
to a sub-inhibitory dose of Ery resulted in differential expression of much fewer genes. Interestingly, two putative drug
efflux operons (cj0309c-cj0310c and cj1173-cj1174) were up-regulated. Although mutation of the two operons did not
alter the susceptibility of C. jejuni to antimicrobials, it reduced Campylobacter growth under high-level oxygen. Another
notable finding is the consistent up-regulation of cj1169c-cj1170c, of which cj1170c encodes a known phosphokinase,
an important regulatory protein in C. jejuni. Mutation of the cj1169c-cj1170c rendered C. jejuni less tolerant to
atmospheric oxygen and reduced Campylobacter colonization and transmission in chickens.
Conclusions: These findings indicate that Ery treatment elicits a range of changes in C. jejuni transcriptome and affects
the expression of genes important for in vitro and in vivo adaptation. Up-regulation of motility and down-regulation of
energy metabolism likely facilitate Campylobacter to survive during Ery treatment. These findings provide new insight
into Campylobacter adaptive response to antibiotic treatment and may help to understand the mechanisms underlying
antibiotic resistance development.
Keywords: Adaptation, Microarray, Transcriptome, Macrolide, Campylobacter
Background
Campylobacter jejuni is a Gram-negative, spiral-shaped,
motile bacterium and is a leading cause of bacterial food-
borne enteritis in humans [1,2]. Most human C. jejuni
infections are acquired by consuming or handling con
taminated poultry, milk or water. Clinical symptoms of
campylobacteriosis can range from mild diarrhea to fever,
headache, abdominal cramping, vomiting and bloody diar-
rhea. Studies also demonstrated that Campylobacter infec-
tion is associated with Guillain-Barré syndrome as a post-
infection complication [3].
Although most campylobacteriosis cases are self-
limiting, antibiotic therapy may be necessary for severe or
persistent illness [4]. Macrolide, such as erythromycin
(Ery), is the drug of choice for treating campylobacteriosis,
but the frequency of resistance to this class of antibiotic is
rising [5,6]. As an inhibitor of protein translation in bac-
terial cells, Ery and other macrolide antibiotics interfere
with aminoacyl translocation, preventing the transfer of
the tRNA bound at the A site to the P site of the rRNA
complex. Without this translocation, the A site remains
occupied and thus precludes the incoming tRNA from
attaching its amino acid to the nascent polypeptide [7-9].
The molecular mechanism of resistance to Ery in C. jejuni
has been extensively studied and is conferred largely by
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target modification (such as mutations in the 23S rRNA
gene and ribosomal proteins) [6,7,10] and antibiotic efflux
pumps [11]. Although the genetic basis of Ery resistance
in C. jejuni has been well characterized, there is very little
knowledge of the initial response and adaptive mechanism
of C. jejuni to Ery exposure.
Transcriptomic analysis has been used to assess bac-
terial adaptive responses to antibiotic treatments. Three
previous studies reported global gene expression pat-
terns of Streptococcus pneumonia [12], Escherichia coli
[13], and Haemophilus influenzae [14] to sub-inhibitory
doses of translation-inhibiting antibiotics. These reports
demonstrated that exposure to these bacteriostatic anti-
biotics triggered the synthesis of a number of ribosomal
proteins [12-14]. Other studies analyzed the transcrip-
tional profiles of Staphlococcus aureus, E. coli, and
Yersinia pestis under inhibitory doses of chlorampheni-
col, mupirocin, ampicillin, or ofloxacin [15-17], and a
common observation of these studies was the repression
of energy metabolism genes by these antibiotics. Al-
though the transcriptomic response of C. jejuni to a
fluoroquinolone antibiotic has been reported [18], it re-
mains unknown how this organism responds to
macrolide treatment.
In this study, the genome-wide transcriptional re-
sponse of C. jejuni following exposure to both inhibitory
and sub-inhibitory doses of Ery was assessed. Further-
more, contribution of several differentially expressed
genes to antibiotic resistance, stress resistance, and host
colonization was determined using isogenic gene knock-
out mutants.
Results
Transcriptional responses of NCTC 11168 to an inhibitory
dose of Ery
To identify the adaptive response of Campylobacter to
Ery treatment, microarray was used to analyze the tran-
scriptional changes in C. jejuni NCTC 11168 following
exposure to Ery. After NCTC 11168 was exposed to an
inhibitory dose of Ery (16× MIC) for 30 min, a total of
258 genes were shown to be differentially expressed,
among which 139 were up-regulated and 119 were
down-regulated (Additional file 1: Tables S1 and S2).
Cluster of orthologous groups (COG) (http://www.ncbi.
nlm.nih.gov/COG/) analysis revealed changes in multiple
functional categories (Table 1). Among the up-regulated
genes, the “cell motility” category showed the highest
percentage (19.23%) of changes. For the down-regulated
Table 1 COG category of differentially-expressed genes in NCTC 11168 in response to treatment with an inhibitory
dose of Ery
COG category No. up-regulated (%)* No. down-regulated (%)* Total No. differentially expressed genes
Amino acid transport and metabolism 14 (11.11%) 12 (9.52%) 26
Carbohydrate transport and metabolism 1 (2.94%) 4 (11.76%) 5
Cell cycle control, mitosis and meiosis 2 (14.29%) 2 (14.29%) 4
Cell motility 10 (19.23%) 2 (3.85%) 12
Cell wall/membrane biogenesis 3 (2.52%) 9 (7.56%) 12
Coenzyme transport and metabolism 7 (10.14%) 3 (4.35%) 10
Defense mechanisms 2 (8.70%) 0 (0.00%) 2
Energy production and conversion 6 (6.32%) 30 (31.58%) 36
Function unknown 9 (12.67%) 3 (4.23%) 12
General function prediction only 12 (8.45%) 10 (7.04%) 22
Intracellular trafficking and secretion 0 (0.00%) 1 (2.17%) 1
Inorganic ion transport and metabolism 9 (11.11%) 4 (4.94%) 13
Lipid transport and metabolism 3 (8.57%) 0 (0.00%) 3
Nucleotide transport and metabolism 1 (2.33%) 4 (9.30%) 5
Poorly characterized 32 (6.00%) 19 (3.56%) 51
Posttranslational modification, chaperones 6 (9.23%) 7 (10.77%) 13
Replication, recombination and repair 3 (5.00%) 3 (5.00%) 6
Signal transduction mechanisms 3 (6.67%) 1 (2.22%) 4
Transcription 6 (13.95%) 1 (2.33%) 7
Translation 10 (10.00%) 4 (4.00%) 14
Total 139 119 258
* This percentage was calculated based on the number of the up or down regulated genes in a category to the total number of the genes in that particular category.
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genes, the “Energy production and conversion” category
showed the highest percentage (31.58%) of changes.
Additionally, a number (85; 33%) of the differentially
expressed genes were in the categories of “poorly charac-
terized”/“function unknown”/”General function predic-
tion only” (Table 1).
Within the up-regulated genes, several belong to puta-
tive transcriptional units (operons) including cj0061c-
cj0062c, cj0309c-cj0310c, cj0345-cj0349, cj0423-cj0425,
cj0951c-cj0952c, and cj1173-cj1174. cj0061c encodes a
flagellar biosynthesis sigma factor and cj0062c encodes a
putative integral membrane protein. Each of the cj0309c-
cj0310c and cj1173-cj1174 operons encodes a putative
multidrug efflux system in C. jejuni. Genes cj0345-
cj0349 are predicted to encode subunits of anthranilate
synthase and tryptophan synthase. cj0423-cj0425 encode
putative integral membrane/periplasmic proteins whose
functions remain unknown. cj0951c-cj0952c encode pro-
teins forming a putative chemoreceptor, which was dem-
onstrated to be associated with host cell invasion,
motility and chemotaxis towards formic acid [19].
Many of the down-regulated genes belonged to the
“energy production and conversion” category (Table 1).
Approximately 31.58% (30 out of 95) of the genes classi-
fied in “energy production and conversion” were down-
regulated in response to the inhibitory Ery treatment. In-
cluded in this category were several putative operons,
such as cj0073c-cj0076c, cj0107-cj0108, cj0437-cj0439,
cj0531-cj0533, cj0781-cj0783, cj1184c-cj1185c, cj1265c-
cj1266c, and cj1566-cj1567. Several ORFs in other COGs
also showed a substantial level of down-regulation and
these included cj0662c-cj0663c, which encode an ATP-
dependent protease ATP-binding subunit HslU and an
ATP-dependent protease peptidase subunit; cj1427c-
cj1428c, which encode two proteins belonging to carbo-
hydrate transport and metabolism; and cj1598-cj1599,
which encode two amino acid transport and metabolism
proteins.
Transcriptional responses of NCTC 11168 to a sub-
inhibitory dose of Ery
To identify differentially expressed genes in response to
a sub-inhibitory concentration of Ery, microarray was
performed on wild-type C. jejuni NCTC 11168. In total,
the expression of 85 genes was altered by the sub-
inhibitory dose (0.5 × MIC) of Ery treatment, of which
39 were up-regulated and 46 were down-regulated
(Table 2; Additional file 1: Tables S3 and S4). More than
half (50.59%) of the differentially expressed genes
encoded hypothetical proteins (included “poorly charac-
terized”/“function unknown”/”General function predic-
tion only”). Several differentially expressed genes were in
the functional category of “amino acid transport and me-
tabolism” (6 were up-regulated and 5 were down-
regulated) (Table 2). The up-regulated genes in this cat-
egory included trpB, trpD, trpA, trpE (cj0348, cj0346,
cj0349, cj0345) encoding tryptophan synthase and
anthranilate synthase subunits, two genes (cj1017c,
Table 2 COG category of differentially-expressed genes in NCTC 11168 in response to treatment with a sub-inhibitory
dose of Ery
COG category No. up-regulated (%)* No. down-regulated (%)* Total No. differentially expressed genes
Amino acid transport and metabolism 6 (4.76%) 5 (3.97%) 11
Carbohydrate transport and metabolism 1 (2.94%) 2 (5.88%) 3
Cell motility 2 (3.85%) 0 (0.00%) 2
Cell wall/membrane biogenesis 0 (0.00%) 3 (2.52%) 3
Coenzyme transport and metabolism 1 (1.45%) 2 (2.90%) 3
Defense mechanisms 1 (4.35%) 1 (4.35%) 2
Function unknown 4 (5.63%) 3 (4.23%) 7
General function prediction only 2 (1.41%) 2 (1.41%) 4
Inorganic ion transport and metabolism 3 (3.70%) 2 (4.94%) 5
Lipid transport and metabolism 1 (2.86%) 2 (5.71%) 3
Poorly characterized 15 (2.81%) 17 (5.71%) 32
Posttranslational modification, chaperones 0 (0.00%) 1 (1.54%) 1
Replication, recombination and repair 0 (0.00%) 1 (1.67%) 1
Signal transduction mechanisms 1 (2.22%) 2 (4.44%) 3
Transcription 2 (4.65%) 2 (4.65%) 4
Translation 0 (0.00%) 1 (1.00%) 1
Total 39 46 85
* This percentage was calculated based on the number of the up or down regulated genes in a category to the total number of the genes in that particular category.
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cj1019c) encoding a branched-chain amino-acid ABC
transport system permease and a periplasmic binding
proteins. Down-regulated genes in this category included
argB (cj0226), cysE (cj0763c), cj0731, cj1582c, and
cj1583c. Fewer than 3 genes were differentially expressed
in other categories (Table 2). Different from the inhibi-
tory treatment, the sub-inhibitory treatment resulted in
much fewer differentially expressed genes in the “tran-
scription” and “translation” categories (Table 2).
Notably, several genes demonstrated consistent changes
in expression under both inhibitory and sub-inhibitory
treatments with Ery and are listed in Table 3. These genes
are involved in motility/chemotaxis, tryptophan synthesis,
branched-chain amino acid transport, and protein phos-
phorylation (cj1170c). A two-component sensor kinase
(cj1226c) was down-regulated under both inhibitory and
sub-inhibitory treatments (Table 3). To confirm differen-
tial expression detected by microarray, qRT-PCR was
conducted on selected genes. The result confirmed most
of the examined genes (Table 4).
Transcriptional responses of EryR C. jejuni JL272 to Ery
treatment
JL272 is an EryR derivative of NCTC 11168 and was iso-
lated from a chicken fed tylosin-containing feed [20].
This strain bears a A2074G mutation in its 23S rRNA
gene, which confers a high-level erythromycin resistance
(MIC = 1024 mg/L) [20]. The transcriptional profile of
this strain was assessed after treatment with 4 mg/L of
Ery, the same concentration used for the inhibitory
treatment of the wild-type strain. Interestingly, only a
total of three genes were up-regulated, while a single
gene was down-regulated. The up-regulated genes were
cj0862c, cj1006c and cj1706c, which encode para-
aminobenzoate synthase component I, a hypothetical
protein and 50S ribosomal subunit protein RplD, re-
spectively. The down-regulated gene, cj0030, encodes a
hypothetical protein. The small number of affected genes
in the EryR strain suggests that little stress is imposed to
JL272 by 4 mg/L of Ery.
Characterization of cj0309c-cj0310c and cj1173-cj1174
Two of the operons up-regulated by Ery treatment were
cj0309c-cj0310c and cj1173-cj1174, which encode puta-
tive small multidrug resistance (SMR) efflux trans-
porters. However, their functions have not been
determined. The SMR family of transporters are charac-
terized by their short length (100–150 amino acids), four
trans-membrane α-helical motifs, and the use of the pro-
ton motive force to export a broad range of antiseptics
and drugs out of the cell [21]. The paired small
multidrug resistance (PSMR) protein family is one of the
SMR sub-classes, which requires co-expression of two
homologues including a typical SMR length protein and
a protein with longer hydrophilic loops [22].
Cj0309c-cj0310c and cj1173-cj1174 belong to the
PSMR family. In the microarray experiment, both pairs
were up-regulated in response to the inhibitory dose of
Ery treatment (Additional file 1: Table S1 and Table 4).
To determine the role of the PSMR genes in adaptive re-
sponse to Ery exposure, C. jejuni NCTC 11168 mutants
carrying a mutation(s) in either (single mutant) or both
(double mutant) PSMR operons were constructed
(Table 5, Figure 1). None of the mutant strains had any
substantial in vitro growth defect compared to the wild-
type strain in MH broth after 48 hours of incubation
Table 3 Differentially-expressed genes in NCTC 11168 in response to inhibitory/sub-inhibitory Ery treatments
Gene
name
Description Fold-change
Inhibitory treatment Sub-inhibitory treatment
cj0061c flagellar biosynthesis sigma factor 4.44 3.03
cj0345 putative anthranilate synthase component I 7.84 5.02
cj0348 tryptophan synthase subunit beta 4.51 2.76
cj0565 Pseudogene 6.12 4.17
cj0698 flagellar basal body rod protein FlgG 5.10 3.45
cj0916c conserved hypothetical protein Cj0916c 4.43 3.29
cj0951c putative MCP-domain signal transduction protein 5.75 4.44
cj0952c putative HAMP containing membrane protein 7.85 2.84
cj1019c branched-chain amino-acid ABC transport system periplasmic binding protein 12.11 3.13
cj1169c putative periplasmic protein 6.91 2.71
cj1170c 50-KDa outer membrane protein precursor 15.34 2.75
cj0168c putative periplasmic protein 0.08 0.29
cj0767c phosphopantetheine adenylyltransferase 0.23 0.24
cj1226c putative two-component sensor (histidine kinase) 0.29 0.30
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under microaerobic conditions (data not shown). Muta-
tion of the PSMR transporter genes, either individually
or in combination, did not substantially change the MIC
toward 14 compounds tested, including Ery (data not
shown; see materials and methods for the compounds
tested).
The involvement of the PSMR efflux systems in aer-
obic and oxidative stress survival in C. jejuni was tested
next. In this experiment, the ability of bacterial cells to
grow on MH agar was assessed under different oxygen
levels (5% O2 or 18.5% O2). The PSMR mutants
and their wild-type strain grew comparably under
microaerobic environment (5% O2) (Figure 2A). How-
ever, under aerobic conditions (18.5% O2), all mutants
showed declined growth compared with the wild-type
strain (Figure 2A) and the decline was more prominent
with KO73Q and DKO01Q (~100 fold difference). To
confirm the phenotype associated with the mutant
strains, a partial complementation of the double knock-
out mutant with the wild-type copy of cj1173-cj1174 was
constructed as described in material and methods. As
shown in Figure 2B, the complementation partly re-
stored the mutant’s ability to grow under high oxygen
tension. These results indicated that the two PMSR sys-
tems facilitate C. jejuni adaptation to aerobic environ-
ment. Additionally, we performed disk diffusion assay
using hydrogen peroxide, cumene, and menadione,
which did not show any significant differences (p > 0.05)
in bacterial growth inhibition between the wild-type and
PSMR mutant strains (result not shown), suggesting that
the two putative efflux systems are not directly involved
in the resistance to the examined oxidants.
Since the PSMR mutants demonstrated enhanced sus-
ceptibility to the high-level oxygen concentration, we
further examined their contribution to colonization of
chickens. Both the wild-type and the mutant strains
were equally motile as determined by swarming on
semi-solid agar. When chickens were mono-inoculated
individually with each mutant strain (KO39Q, KO73Q
or DKO01Q), there was no significant difference in the
level of colonization among the wild-type and mutant
strains for the duration of study, i.e., 15 days after inocu-
lation (Figure 3A and B). Additionally, a co-mingling
chicken experiment using the double knockout mutant
and wild-type strain was performed in order to deter-
mine the role of the PSMR genes in horizontal transmis-
sion in birds. In the comingling group with seeder birds
inoculated with the double knockout mutant, 67% of the
naive chickens were positive for DKO01Q at 3 days after
initiation of co-mingling, and all the birds became posi-
tive at 6 and 9 days after initiation of co-mingling
(Figure 3C). For the comingling group with seeder birds
inoculated with the wild-type strain, 90% of the naive
birds were colonized with NCTC 11168 at 3 days after
initiation of comingling, and all colonized at 6 and 9
days after initiation of comingling (Figure 3C). The
colonization levels in the non-inoculated, but comingled
birds also showed no significant differences between the
two groups (Figure 3D). Together, the chicken experi-
ments indicated that the two PSMR efflux systems, indi-
vidually or in combination, are dispensable for C. jejuni
colonization and horizontal spread in the chicken host.
Characterization of the cj0423-cj0425 operon
cj0423-cj0425 encode a putative integral membrane pro-
tein, a putative acidic periplasmic protein and a putative
periplasmic protein, respectively. Microarray showed
that this operon was up-regulated under treatment with
an inhibitory dose of Ery (Additional file 1: Table S1).
Additionally, qRT-PCR results demonstrated that cj0425
was up-regulated under both inhibitory and sub-
inhibitory Ery treatments in NCTC 11168 (Table 4).
Amplification of cj0423-cj0425 by a conventional RT-
PCR (primers are listed in Table 6) confirmed that
cj0423-cj0425 were co-transcribed (data not shown),
suggesting an operon-like structure. To characterize the
function of this operon, all three genes were deleted to
generate mutant KO423Q as described in materials and
methods. The mutation did not affect the transcript
abundance of the downstream gene (cj0426) as qRT-
Table 4 qRT-PCR confirmation of representative
differentially expressed genes initially identified by
microarray
Gene Ery-treatment qRT-PCR Microarray
FC** P* value FC P* value
cj0061c Inhibitory 7.92 0.01 4.44 0.01
cj0061c Sub-inhibitory 2.60 0.03 3.03 0.01
cj0258 Inhibitory 0.71 0.35 0.70 0.43
cj0258 Sub-inhibitory 2.33 0.08 6.88 0.01
cj0310c Inhibitory 2.77 0.05 5.49 0.01
cj0310c Sub-inhibitory 2.07 0.02 1.82 0.14
cj0345 Inhibitory 29.10 0.01 7.84 0.01
cj0345 Sub-inhibitory 6.94 0.03 3.93 0.01
cj0425 Inhibitory 6.80 0.01 107.44 0.01
cj0425 Sub-inhibitory 6.61 0.01 2.01 0.05
cj1170 Inhibitory 55.71 0.01 15.34 0.01
cj1170 Sub-inhibitory 4.21 0.17 2.75 0.01
cj1173 Inhibitory 6.38 0.02 4.31 0.01
cj1173 Sub-inhibitory 3.65 0.01 1.43 0.19
cj1226 Inhibitory 0.07 0.01 0.29 0.01
cj1226 Sub-inhibitory 1.72 0.29 0.31 0.01
cj1563 Inhibitory 1.95 0.03 4.97 0.01
cj1563 Sub-inhibitory 1.61 0.01 0.86 0.53
* P values smaller than 0.01 are shown as 0.01.
** FC denotes fold-change.
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PCR revealed no significant difference in the transcript
quantity of cj0426 between the wild-type and the mutant
strain (p = 0.07). When the wild-type strain and
KO423Q were compared for in vitro growth in MH
broth, there were no significant growth rate differences
at 24 h and 48 h (data not shown). In addition, Ery MIC
of KO423Q was the same as that of the wild-type strain
(0.25 mg/L). Moreover, no appreciable difference was
evident for oxidative stress resistance (H2O2, cumene
hydroperoxide, and menadione) between the wild-type
and the mutant strains (results not shown).
Characterization of cj1169c-cj1170c operon
The microarray and qRT-PCR results demonstrated that
cj1169c and cj1170c were up-regulated in both inhibitory
and sub-inhibitory treatments with Ery (Tables 3 and 4).
cj1169c and cj1170c encode a putative periplasmic pro-
tein and a 50 kDa outer membrane protein precursor,
respectively [23]. Recently, cj1170c was characterized as
an outer-membrane tyrosine kinase, phosphorylating a
number of membrane proteins [24]. To identify the role
of the two genes in adaptation to Ery treatment, both
genes were deleted to produce the mutant strain
KOp50Q. The mutation did not affect the transcript
abundance of the downstream gene, cj1168c, as deter-
mined by qRT-PCR (data not shown). The mutant was
complemented to produce strain Comp50Q.
The wild-type and mutant strains demonstrated com-
parable growth rates in MH broth without or with sub-
inhibitory (1/2, 1/4, 1/8, and 1/16× MIC) concentrations
of Ery (data not shown). Additionally, no significant differ-
ence in motility was observed between the mutant and
wild-type strains. Furthermore, the MIC test revealed no
significant differences between the wild type strain and
KOp50Q in susceptibility to a number of antimicrobials
including ampicillin, erythromycin, tylosin, ciprofloxacin,
tetracycline, phosphonomycin, cetylpyridinium chloride,
chloramphenicol, nalidixic acid, novobiocin, ethidium
bromide and crystal violet (results not shown). Likewise,
as shown by the disk diffusion assay, no significant differ-
ences were revealed between the mutant and wild-type
strains in sensitivity to oxidative stress agents including
H2O2 and cumene hydroperoxide (data not shown). How-
ever, the aerobic stress experiments indicated that the
Table 5 Bacterial strains and plasmids used in this study
Strain or plasmid Description or relevant genotype Source or reference
Bacterial strains
NCTC 11168 Campylobacter jejuni wild-type strain ATCC*
JL272 NCTC 11168 derivative erythromycin resistant strain Jun Lin [20]
KOp50Q NCTC 11168 Δcj1169c-cj1170c::cat mutant This study
KO423Q NCTC 11168 Δcj0423-cj0425::aphA3 mutant This study
KO39Q NCTC 11168 Δcj0309c-cj0310c::cat mutant This study
KO73Q NCTC 11168 Δcj1173-cj1174::aphA3 mutant This study
DKO01Q NCTC 11168 Δcj0309c-cj0310::cat, Δcj1173-cj1174::aphA3 mutant This study
Comp50Q KOp50Q complementation strain; Δcj1169c-cj1170c::cat, ITS1::cj1169c-cj1170c complementation strain This study
ComDK01Q DKO01Q complementation strain; Δcj0309c-cj0310::cat, Δcj1173-cj1174::aphA3, ITS1::cj1173-cj1174 This study
DH5α Escherichia coli strain for plasmid propagation Invitrogen
Plasmids
pUC19 Polymerase chain reaction cloning vector, AmpR** Promega
pRR Complementation cloning vector Karlyshev [40]
pRRK pRR with aphA3; KanR** This study
pRRT pRR with tetO; TetR** This study
pUp50Q cj1169c-cj1170c::cat cloned into pUC19 This study
pU423Q cj0423-cj0425::aphA3 cloned into pUC19 This study
pU39Q cj0309c-cj0310c::cat cloned into pUC19 This study
pU74Q cj1173-cj1174::aphA3 cloned into pUC19 This study
pRRKp50Q cj1169c-cj1170c cloned into pRRK This study
pRRK39Q cj0309c-cj0310c cloned into pRRK This study
pRRT73Q cj1173-cj1174 cloned into pRRT This study
*ATCC: American type culture collection (ATCC number for this strain is 700819).
**AmpR: Ampicillin resistance, KanR: Kanamycin resistance, TetR: Tetracycline resistance.
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GF                                       GR                                                  HF                              HR
(b)                                                                            aphA3
AF                       AR                           BF                     BR
cj0308c                   cj0309c          cj0310c               cj0311
cj0422c                     cj0423                     cj0424                       cj0425                            cj0426
(c)                                                                                        cat
(d)                                                                                     
aphA3
cj1172c                                  cj1173                                    cj1174                                    cj1175c     
EF                              ER                                                FF                                         FR
cj1168c                                  cj1169c                         cj1170c                                      cj1171c
CF                                   CR                                         DF                                          DR
(a) cat
Figure 1 Construction of mutant strains. ORFs are indicated by boxed arrows (not drawn to scale). The locations of the primers used to
amplify the fragments and generate the deletions are indicated by solid arrows. The dash line box indicated the location of the deletion of
chromosomal sequence and insertion of an antibiotic resistant cassette (cat or aphA3). (a), (b), (c), and (d) are diagrams for operons
cj0309c-cj0310c, cj0423-cj0425, cj1169c-cj1170c and cj1173-cj1174, respectively.
Microaerobic (5% O2)                            18.5% O2
NCTC 11168
KO39Q
KO73Q
DKO01Q
NCTC 11168
DKO01Q
ComDK01Q
NCTC 11168
KOp50Q
Comp50Q
C
B
A
Figure 2 Comparison of oxygen tolerance of C. jejuni wild-type NCTC 11168 and its mutant strains. For (A) and (C), 5 μl of serial dilutions
(from left to right: 107-101 CFU/ml) of overnight cultures were spotted onto MH agar plates and incubated at either 18.5% or 5% O2. For (B), 5 μl
of serial dilutions (from left to right: 105-101 CFU/ml) of overnight cultures were spotted onto MH agar plates and incubated at either 18.5% or
5% O2. Results are representative of three independent experiments.
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mutant was more susceptible than the wild-type strain to
higher levels of oxygen, although they showed comparable
growth under microaerobic conditions (Figure 2C). Com-
plementation of the mutant (Comp50Q) partially restored
the phenotype to the wild-type level (Figure 2C).
To determine the role of cj1169c-cj1170c in
colonization of and horizontal transmission between
birds, a co-mingling chicken experiment was performed
with wild-type, mutant (KOp50Q) and complement
strains (Comp50Q). All 3 seeder birds in each group be-
came Campylobacter-positive for the respectively inocu-
lated strain at 3 days after inoculation (DAI) as
determined by cloacal swabbing and culturing on select-
ive plates. The three KOp50Q-inoculated seeder birds
showed attenuated colonization levels compared with
those inoculated with the wild-type strain (p = 0.02),
while the complement strain resulted in comparable
colonization level to that of the wild-type strain (p =
0.32) as determined by culturing cecal contents collected
at necropsy on 9 or 12 DAI (Figure 4A). The co-
mingling experiment showed that 3 days after the initi-
ation of co-mingling, 90% and 50% of the naive (non-in-
oculated) chickens were colonized by the wild-type and
complement strains, respectively, while none of the
naive chickens in the KOp50Q group was Campylobac-
ter positive on the same day (Figure 4B). This difference
was statistically significant (p < 0.05). At 6 days after ini-
tiation of co-mingling, all of the naive birds in the wild-
type group were positive, while 67% of the naive birds
were positive in the KOp50Q group and 90% were posi-
tive in the complement group. The differences were not
statistically significant. At 9 days after initiation of co-
mingling, all the naive birds were positive in all three
groups as determined by culturing cloacal swabs
(Figure 4B). In addition to the cloacal swabs, cecal con-
tents were collected from the naive birds necropsied on 9
and 12 days after initiation of co-mingling to determine
colonization levels. At 9 days after initiation of co-
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Figure 3 Effect of the PSMR gene mutations on Campylobacter colonization and transmission in chickens. (A) Colonization levels of
single-mutant strains KO39Q and KO73Q in comparison with the wild-type strain NCTC11168. (B) Colonization levels of double mutant DKO01Q
in comparison with the wild-type strain NCTC11168. In (A) and (B), cecal contents were collected from chickens necropsied on DAI 5, 10, and 15.
Each symbol represents data from a single bird and bars indicate the mean ± SD for each group. Dashed lines indicate the detection limit of the
direct plating method. (C) and (D): Co-mingling experiment demonstrating the transmission of C. jejuni from seeder birds (n = 3 in each group) to
naive (non-inoculated) birds. (C) The percentage of naive birds (n = 10 for the wild type group and n = 9 for DKO01Q group) positive for C. jejuni
after comingling with seeder birds inoculated with NCTC11168 and DKO01Q, respectively. (D) Cecal colonization levels of the wild-type strain and
DKO01Q strains in naive birds co-mingled with the seeder birds. The birds were euthanized at 9 and 12 days after initiation of co-mingling. Each
symbol represents the colonization level of a single bird and the horizontal bars indicate the mean and standard error for each group.
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mingling, the naive birds colonized by KOp50Q or by
Comp50Q had fewer C. jejuni than the naive birds colo-
nized by the wild-type strain (Figure 4C) and the differ-
ence was statistically significant (p < 0.05). At 12 days
after initiation of co-mingling, naive birds were colonized
by KOp50Q or Comp50Q at similar levels to the wild-
type group (p > 0.05).
Discussion
In this study, we determined the transcriptomic changes
in C. jejuni in response to Ery treatment in an attempt
to identify initial molecular mechanisms involved in
adaptation to macrolide challenge and resistance devel-
opment. Wild-type Ery-susceptible C. jejuni NCTC
11168 was exposed to different doses of Ery to reveal
the adaptive responses to inhibitory and sub-inhibitory
antibiotic challenges. In addition to NCTC 11168, its
EryR derivative JL272 strain was also exposed to Ery at a
concentration considered inhibitory for the wild-type
(4 mg/L). A relatively short treatment period (30 min)
was chosen in order to minimize possible collateral ef-
fects that might occur from prolonged drug treatment.
Transcriptomic analyses revealed a number of genes
with altered expression levels in response to Ery treat-
ment, of which the most obvious changes are up-
regulation of genes involved in cell motility and down-
regulation of genes involved in energy production
(Table 1).
Ery and other macrolide antibiotics block the ribosome
elongation tunnel to prevent movement and release of
the nascent peptide during bacterial protein synthesis.
Previous studies have demonstrated that treatment of E.
coli and H. influenza with translation inhibitors (such as
puromycin, tetracycline, chloramphenicol, and erythro-
mycin) increased the relative synthesis rate of a number
of ribosomal proteins and translation factors as a pos-
sible compensating mechanism [12,14]. Consistent with
the findings in other bacteria, treatment of C. jejuni with
an inhibitory dose of Ery increased the transcription of
Table 6 Primers used in this study
Primers Sequence*(5’→ 3’) (restriction enzyme)
Primers for mutant
construction
cj0308c-F(AF) CTCGAATTCCCTTTTCCATAGATGTTTGC (EcoRI)
cj0309c-R (AR) CCAGGTACCAAATTTCACAGGCAGTAGCT(KpnI)
cj0310c-F (BF) GAATCTAGAGTGGGGTAATGATAGGAGTG(XbaI)
cj0311-R (BR) CCAGTCGACCAAGGGCTAAAAGATTGATA (SalI)
cj0422c-F (CF) GCCGAATTCAATAAGGGTTGTAATTGAAGCG (EcoRI)
cj0423-R (CR) AATGGTACCTGCTCAAACCAATAATAGCG(KpnI)
cj0425-F (DF) TTTGCTAGCGGACTA TTATTGTTTGGCTTGT (NheI)
cj0426-R (DR) ATCCTGCAGGTCTAATGAGTTGGCCTGAA (PstI)
cj1168c-F(EF) AGCGAATTCACAGAACCTAAAGTCCCA (EcoRI)
cj1169c-R (ER) AATCGGTACCATCCAGAGCCAGAGTCAAA(KpnI)
cj1170c-F (FF) AAATCTAGAATGAAAGAAGACAAGCACT(XbaI)
cj1171c-R (FR) TTGGCATGCTAGAAACTGAAAAAGGCAC (SphI)
cj1172c-F (GF) ACAGAATTCACGGTGCGTGTAGGGTT (EcoRI)
cj1173-R (GR) ACTGGTACCACAATAGCAGCAATCAAGAA(KpnI)
cj1174-F (HF) GGTTCTAGAGGCATCATAGGAACTTGTCT(XbaI)
cj1175c-R (HR) GGTCTGCAGATCGATGATGTAATGAAAGC (PstI)
16S-F ATCGTAGATCAGCCATGCTA
Primers for
complementation
construction
cj1169c-cj1170c-F TTGTCTAGAAAAAGATTAAACAGTAA(XbaI)
cj1169c-cj1170c-R AACTCTAGAACAAGGAGTTATGATTA(XbaI)
cj1173-cj1174-F TATTCTAGACAGTGCCACCTTCTTTAGCG(XbaI)
cj1173-cj1174-R CCGTCTAGACTTTAATGGGTATTGAAGCA(XbaI)
Primers for qRT-PCR
qRT-16S-F TCCCAGTTCGGATTGTTCTC
qRT-16S-R GTACAAGACCCGGGAACGTA
cj0061-F GAAGGCAAGCGTTCTTTTAGTCT
cj0061-R AGAAAGAGCAAGATGAGCTTGTG
cj0258-F GTGAAAATGCCGATGAAAATG
cj0258-R GCGATGATGGTAGGTTTACTTTG
cj0310c-F TAGAGTGCTTTTGGGTAAGTGGA
cj0310c-R AATACAAACCCCAATGGCTGTTA
cj0345-F TATGGTGTTGTTTTGGGTTCTTC
cj0345-R CCAGCAATAGGGGCTAAATAAAT
cj0425-F CTTCAGGCCAACTCATTAGA
cj0425-R GGGCTTTAAGTCCGGATAATTC
cj0426-F AACCTTGATTTAGAGGCGATTTC
cj0426-R GCCTATCATGAGAGATGACAACC
cj0767-F ATGGTTTCCATATCTTCCCAAAG
cj0767-R TAATCCGTGGACTTAGAGCAGTG
cj1168c-F CAAGTATAGCCACCCAAATAGCA
cj1168c-R TTACCAGGGATTCGTCAGTACAT
cj1170-F CAAAATCAGTCATATGAGCCACA
cj1170-R CTATGCTGCAGTAGAAGGAGAGC
Table 6 Primers used in this study (Continued)
cj1173-F CTGTATGGGAGCTTTTAGGGATT
cj1173-R TCCAACGATAGAAAGAACAATGC
cj1226-F GCTTTGCTTCTGTTATCTCATCC
cj1226-R AGGCTCTTAAATTTTGCAGGAGT
cj1563-F GCAGTTTTTATACCCAAAGAGCA
cj1563-R GCGATATAGAATGGGTAAAATGG
Primers for
conventional RT-PCR
cj0423-F GCGGGTCTATTTTTGTA
cj0425-R CTTGGCTATTTCCTTGA
*Underlined sequences indicate recognition site for the corresponding
restriction endonuclease, which is shown in parenthesis.
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ribosomal proteins, translation initiation factor (IF-1)
and transcription elongation factor (nusA) (Table 1;
Additional file 1). This finding suggests that C. jejuni in-
creases transcription of these genes in order to help re-
cover halted peptide elongation and resume translation
as its immediate response against the antibiotic expos-
ure. Interestingly, treatment of an EryR strain (JL272)
with a dose of Ery inhibitory for its wild-type ancestor
did not trigger noticeable transcriptomic responses. This
observation suggests that the 23S RNA mutation in
JL272 prevented the interaction of Ery with its target
and consequently prohibited the induction of a
transcriptomic response in C. jejuni.
Of note, several functional gene categories were sig-
nificantly affected in the wild-type C. jejuni by an inhibi-
tory dose of Ery (Table 1), suggesting that C. jejuni alters
multiple pathways to cope with Ery stress. Most of the
differentially expressed genes in the COG category “en-
ergy production and conversion” were down-regulated
(Table 1), suggesting that reduced energy metabolism
occurred as an adaptive response to inhibitory treatment
with Ery. This result is consistent with findings in other
bacteria such as Staphlococcus aureus, E. coli, and Y.
pestis, which demonstrated significant down-regulation
of “energy metabolism” genes under treatment with dif-
ferent classes of antibiotics [15-17]. Taken together,
these observations suggest that reduced energy metabol-
ism may be a general transcriptional response to
antibiotic-induced stress in both Gram-positive and
Gram-negative bacteria. Other COG categories with a
noticeably high proportion of down-regulated genes (as
compared with the proportion of up-regulated genes in
the same categories) included “cell wall/membrane bio-
genesis”, “carbohydrate transport and metabolism”, and
“nucleotide transport and metabolism” (Table 1 and
Additional file 1). These changes suggest that C. jejuni
decreased the general metabolic rates to prolong the sur-
vival time under Ery challenge.
Genes involved in “transcription” and “translation” was
noticeably up-regulated. In the COG category of “tran-
scription”, up-regulated genes included flagellar biosyn-
thesis sigma factor (fliA), putative transcriptional
regulator (cj1563c), transcription elongation factor NusA
(nusA) and heat-inducible transcription repressor (hrcA)
(Additional file 1). Among the up-regulated genes in the
“translation” category included 50S ribosomal protein L1
(rplA), L20 (rplT), 30S ribosomal protein S2 (rpsB), and
translation initiation factor IF-1 (infA) (Additional file
1). Since Ery targets 50S ribosomal proteins and block
the ribosome elongation tunnel, this finding suggests
that C. jejuni increases transcription of these genes in
order to help recover the halted peptide elongation and
resume translation as its immediate response against the
antibiotic exposure. In the “Defense mechanism” cat-
egory, two genes were up-regulated after inhibitory
treatment, which encode putative MATE family trans-
port protein (cj0619) and ABC-type transmembrane
transport protein (cj0607). The role of these genes in the
adaptation to Ery treatment remains undetermined.
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Figure 4 Effect of mutating the cj1169c-cj1170c operon on
Campylobacter colonization and transmission in birds. (A)
Colonization levels in chickens inoculated with wild-type NCTC11168,
KOp50Q, and Comp50Q, respectively. The birds were necropsied on 9
and 12 DAI. Each symbol represents a single bird. Horizontal bars
indicate the mean and standard error for each group. (B) Transmission
of C. jejuni from seeder birds to naive (non-inoculated) birds. The
percentage of naive birds positive for C. jejuni in each group was
shown. (C) Cecal colonization levels of the wild-type, KOp50Q, and
Comp50Q in naive birds co-mingled with seeder birds. The birds were
sacrificed at 9 and 12 days after initiation of co-mingling. Each symbol
represents the colonization level in a single bird. The horizontal bars
indicate the mean and standard error for each group.
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The “cell motility” category comprised the largest pro-
portion of up-regulated genes in response to an inhibi-
tory dose of Ery in wild-type C. jejuni (Table 1),
suggesting that enhanced motility might be Campylobac-
ter’s initial escape response to this noxious stress.
cj0061c, which encodes the σ28 transcription factor fliA
and is essential for normal flagellar biosynthesis [25], is
up-regulated in NCTC 11168 when treated with inhibi-
tory and sub-inhibitory doses of Ery (Table 3). This gene
induction was independently confirmed by qRT-PCR
(Table 4). Previous research indicated that σ28 regulates
the major flagellin gene (flaA) and other late genes of
the flagellar regulon as well as some non-flagellar genes
in C. jejuni [26]. Also, it has been demonstrated that the
flaA promoter can be activated by the intestinal environ-
ment and C. jejuni chemotactic effectors, such as bovine
bile, deoxycholate, L-fucose, osmolarity, aspartate, glu-
tamate, organic acids citrate, fumarate, α-ketoglutarate
and succinate [27]. The microarray and qRT-PCR results
presented here revealed that Ery induced expression of
this regulatory gene (fliA), which might explain why
multiple motility genes were up-regulated in C. jejuni
under Ery treatment.
Compared with the inhibitory-dose Ery treatment,
sub-inhibitory dose Ery triggered a much smaller re-
sponse in the overall transcription in C. jejuni (Table 2
and Additional file 1). There were no or limited changes
in most COG categories, except for “poorly character-
ized” and “amino acid transport and metabolism”. For
example, no differentially expressed genes were found in
the “energy production and conversion” category under
sub-inhibitory Ery treatment (Table 2), while a large por-
tion of genes in this category were down-regulated
under the treatment of an inhibitory does of Ery
(Table 1). In the “cell motility” category, only two genes
were up-regulated under the sub-inhibitory Ery treat-
ment, but a number of genes in this category were up-
regulated in response to an inhibitory dose of Ery
(Table 1). Additionally, no genes in the “translation” cat-
egory were altered in expression under the sub-
inhibitory dose, but multiple genes in this category were
up-regulated when treated with an inhibitory dose.
These differences suggest that the sub-inhibitory dose of
Ery did not significantly affect the fundamental metabol-
ism of C. jejuni. Despite these major differences, there
were 14 genes that showed consistent trends of differen-
tial expression under both inhibitory and sub-inhibitory
treatments (Table 3). Among the 14 genes include
a two-component sensor kinase (cj1226c), omp50
(cj1170c), and fliA (cj0061c). Interestingly, several COG
categories did not show any appreciable gene expression
changes regardless of the doses of Ery exposure. These
categories include cell “cycle control, mitosis and mei-
osis”, “intracellular trafficking and secretion” as well as
those involved in transport and metabolism of lipids and
nucleic acids (Tables 1 and 2). Together, these findings
suggest that Ery exposure invokes transcriptional re-
sponses that are more prominent in certain metabolic
pathways and are influenced by the doses of the
antibiotic.
Several differentially expressed genes were selected for
detailed studies by generating insertional mutants in the
study. The selection was based on their predicted or
known functions (for the PMSR genes and the cj1169c-
cj1170c operon) or the magnitude of differential expres-
sion (for the cj0423-cj0425 operon). Interestingly, muta-
tion of these selected genes did not affect the
susceptibility of C. jejuni to Ery, although their expres-
sion was up-regulated in the presence of this antibiotic.
This finding suggests that these genes are involved in
the response to Ery treatment, but may not contribute
directly to macrolide resistance. Alternatively, these
genes may contribute to Ery resistance when they are
over expressed. This possibility is not examined in this
study and remains to be evaluated. Additionally, func-
tional redundancy of genes may compensate for the in-
activation of the selected genes, preventing an obvious
change in the susceptibility to Ery.
PSMR transporters in other bacteria have been dem-
onstrated to confer resistance to numerous toxic com-
pounds including quaternary ammonium compounds,
toxic lipophilic compounds, potentially toxic metabolites
and polyamine compounds [21,28,29]. Not all PSMR
proteins are associated with an antibiotic resistance
phenotype [34], highlighting the diversity in substrate
recognition by PSMR transporters. In C. jejuni, the sub-
strates recognized and exported by Cj0309c-Cj0310c and
Cj1173-Cj1174 remain unknown. However, their mu-
tants showed reduced survival compared to the wild-
type strain at 18.5% O2 (Figure 2A), suggesting that the
PSMR proteins may contribute to Campylobacter
survival under high-level oxygen tension such as the
conditions encountered outside of the host during trans-
mission. However, the chicken experiments demon-
strated that the mutant strains were comparable to the
wild-type strain in the ability to colonize and spread
among birds (Figure 3), suggesting that the Campylobac-
ter PSMR transporters are not essential for in vivo
colonization and transmission. One potential caveat of
the chicken experiment is the short-term nature of the
study and the continuous shedding of fresh Campylo-
bacter (from the seeder birds) that were available for the
naïve birds, which may not allow evaluation of the role
of the PSMR genes in long-term survival and transmis-
sion. This possibility requires further examination in fu-
ture studies.
cj0425 was identified as up-regulated (>100 fold) by
microarray when C. jejuni was treated with an inhibitory
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dose of Ery (Additional file 1), and qRT-PCR confirmed
this change (Table 4). In this study, we provided empirical
evidence that cj0423-cj0425 are co-transcribed from the
same operon (data not shown). Little is known about the
function of this operon. Previously, it was demonstrated
that cj0425 (encoding a putative periplasmic protein) was
down-regulated under low oxygen conditions and is con-
sidered to be involved in oxidative-tolerance phenotype of
C. jejuni [30,31]. However, it is shown in this study that C.
jejuni wild-type NCTC 11168 and its Δcj0425 isogenic
mutant strain (KO423Q) had comparable level of resist-
ance to the oxidative stress generating compounds tested
in this study (result not shown), suggesting that it is not
directly involved in oxidative stress resistance.
Omp50 (cj1170c) of C. jejuni was previously character-
ized to belong to the monomeric group of porins which is
typical of the OmpA-like family [23]. Omp50 was also
found to be species-specific and present only in C. jejuni
and C. lari, but not in C. coli [32]. Previous studies showed
that the temperature regulated Omp50 maybe an alterna-
tive porin to the major outer membrane protein (MOMP),
contributing to decreased membrane permeability while
still allowing nutrient uptake [33,34]. However, a
recent study identified Omp50 as an outer-membrane
phosphotyrosine kinase that modulates phosphorylation of
multiple outer membrane proteins and carbohydrate bio-
synthesis in C. jejuni [24]. Specifically, Omp50 positively
regulates UDP-GlcNAc/Glc 4-epimerase, which is required
for N-glycosylation, capsule production and virulence. In
this study, it was found that expression of Omp50 and the
downstream gene cj1169c was up-regulated in response to
both high and low doses of Ery treatment (Tables 3 and 4).
This up-regulation could be an adaptive response as in-
creasing expression of surface polysaccharides is expected
to reduce cell permeability to Ery, which is a hydrophobic
antibiotic. Additionally, it was shown in this study that the
Omp50 mutant (KOp50Q) was less tolerant than the wild-
type to high levels of oxygen (Figure 2C), showed reduced
colonization in chickens, and delayed transmission be-
tween seeder birds and non-inoculated birds (Figure 4).
These phenotypic changes could be explained by the role
of Omp50 in protecting Campylobacter against reactive
oxygen species produced by host intestinal epithelium [24]
and against high oxygen tension encountered during fecal-
oral transmission. Together, these findings suggest that the
cj1169c-cj1170c operon contributes to Campylobacter
adaptation in vitro and in animal hosts.
Conclusions
In summary, the findings from this study indicate that
Ery treatment of C. jejuni elicits a transcriptomic re-
sponse that affects a wide range of functional categories.
The most notable changes are up-regulation of motility
genes and down-regulation of genes involved in energy
production and conversion. The transcriptomic response
is influenced by the doses of Ery and is prevented by the
resistance-conferring mutation in the 23S RNA. Inacti-
vation of several selected genes did not affect the sus-
ceptibility of C. jejuni to Ery, but some of the mutant
strains showed reduced tolerance to oxygen in vitro and
decreased colonization in chickens. Together, these re-
sults suggest the adaptive responses may contribute to
the survival of C. jejuni under antibiotic stress and facili-
tate the development of Ery-tolerant/resistant variants.
Methods
Strains, media, and growth conditions
Bacterial strains and plasmids used in this study are
listed in Table 5. Campylobacter strains were routinely
cultured from frozen stocks (−80°C) on Mueller-Hinton
(MH) agar or broth at 42°C under microaerobic condi-
tions (85% N2, 10% CO2 and 5% O2). For oxygen-stress
experiments, the strains were grown on MH agar under
an increased oxygen containing atmosphere (76.5% N2,
5% CO2, and 18.5% O2) at 37°C. E. coli was grown in
Luria-Bertani (LB) broth or agar at 37°C. The media was
supplemented with chloramphenicol (4 mg/L; ACROS),
kanamycin (30 mg/L; Sigma), or tetracycline (5 mg/L;
Sigma) when needed.
Growth rate and antibiotic susceptibility test
To assess in vitro growth, C. jejuni strains were inocu-
lated into MH broth to a density of 107 CFU mL-1 and
incubated with shaking (160 rpm) at 42°C under
microaerobic conditions. Optical density at 600 nm
(OD600) was monitored by a spectrophotometer (Bio-
Rad smartspec™3000, Hercules, CA) at various time
points (2 h, 4 h, 6 h, and 8 h post inoculation).
The minimum inhibitory concentrations (MIC) of Ery
and other antimicrobials for NCTC 11168 and its mu-
tant strains were determined by a microtiter broth dilu-
tion method as described previously [35]. The antibiotics
and compounds were purchased from Sigma (ampicillin,
Ery, streptomycin, novobiocin, nalidixic acid, tetracyc-
line, phosphonomycin, cetylpyridinium chloride), Fisher
Scientific (crystal violet, erythromycin), ACROS (chlor-
amphenicol), IBI Scientific (ethidium bromide (EB)),
Fluka (ciprofloxacin), Ambion (SDS), and Alfa Aesar
(spermidine). Results were recorded after 24 h incuba-
tion under microaerobic conditions at 42°C. Tests for
each compound were repeated three times.
DNA microarray experiments
Wild-type C. jejuni NCTC 11168 (Ery MIC: 0.25 mg/L)
and its erythromycin-resistant (EryR) derivative strain
JL272 (Ery MIC: 1024 mg/L) [36] were grown separately
for 5 hours in MH to OD600 of approximately 0.2 with
shaking (160 rpm) at 42°C under microaerobic
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condition. Fifteen mL aliquots of NTCT 11168 culture
(in triplicates) were treated with either sham (ethanol
solvent for Ery), an inhibitory dose of Ery (4 mg/L; 16×
MIC), or a sub-inhibitory dose of Ery (0.125 mg/L; 0.5×
MIC). All cultures including the sham control were
thoroughly mixed and statically incubated under
microaerobic conditions for 30 minutes at 42°C. Strain
JL272 was treated with 4 mg/L Ery (16× MIC of the
wild-type strain) or the sham under the same condition
as with NCTC 11168. After 30 minutes treatment, the
cultures were immediately mixed with RNAprotect™
(Qiagen, Valencia, CA) to stabilize the total bacterial
RNA. Total RNA was extracted using the RNeasy Mini
kit (Qiagen) according to the manufacturer’s protocol
and treated with TURBO DNase (Invitrogen, Carlsbad,
CA). RNA quantity was determined by OD260 reading
using a NanoDrop spectrometer (Thermo Scientific,
Wilmington, DE), and the purity was assessed by de-
naturing agarose gel electrophoresis. RNA samples con-
firmed free of DNA contamination by PCR of 16S rRNA
gene, were stored at −80°C until use. Three independent
RNA isolations (biological replicates) were performed
for microarray experiments.
C. jejuni microarray slides (version 3 for NCTC 11168
inhibitory treatment, version 4 for NCTC 11168 sub-
inhibitory treatment, and version 1 for JL272 Ery
treament) were designed and provided by the Pathogen
Functional Genomics Resource Center (PFGRC) at the J.
Craig Venter Institute (JCVI, Rockville, MD). cDNA syn-
thesis, labeling of cDNA and hybridization of labeled
cDNA to the microarray slides were performed
according to the JCVI’s protocol (http://pfgrc.jcvi.org/
index.php/microarray/protocols.html). For each pair of
treated and untreated samples, hybridizations were
performed with RNA samples prepared from three inde-
pendent experiments, with the cDNA alternately labeled
with Cy3 and Cy5 for the pair in each slide.
Slides were dried using a microarray high speed centrifuge
(Arrayit, Sunnyvale, CA) and immediately scanned at a
wavelength of 550 nm for Cy3 and 650 nm for Cy5 using a
General Scanning ScanArray 5000 (PerkinElmer, Boston,
MA) at 10 μm resolution. Slide information and annotation
files were obtained from the JCVI website (http://pfgrc.jcvi.
org/index.php/microarray/available_microarrays/.html). The
fluorescence intensities were collected and converted to
digital signal by ImaGene software (BioDiscovery, EI
Segundo, CA). The fluorescence intensity values were
logarithm-transformed, median background corrected, and
LOWESS normalized. The normalized gene expression data
were analyzed using moderated-t test implemented in the R
package, LIMMA [15]. In this study, a p-value < 0.01, rela-
tive fold-change ≥ 2 were chosen as the cutoff for identifica-
tion of genes with a significant differential expression
between the treatment and control samples. The microarray
data have been deposited in the NCBI Gene Expression
Ommibus (http://www.ncbi.nlm.nih.gov/gds/) and the ac-
cession number is GSE43026.
Quantitative real-time RT-PCR
A quantitative real-time RT-PCR (qRT-PCR) was used to
confirm the expression levels of representative genes that
were identified as differentially expressed by the micro-
array. Briefly, reactions were performed using the iQTM
SYBRR Green Super Mix (Bio-Rad, Hercules, CA) and
MyiQTM instrument (Bio-Rad). Primers were designed
by Primer 3 software (http://frodo.wi.mit.edu/) and are
listed in Table 6. The 16S rRNA transcript was used to
normalize target gene expression. Amplification efficiency
and relative transcript abundance (R) were calculated as
previously described [37]. R values were log2 transformed
to meet assumptions of normality and variance; statistical
significance was determined by the two tailed Student’s t-
test under the null hypothesis of R = 0.
Construction and complementation of insertional mutants
Isogenic C. jejuni NCTC 11168 mutant strains with
a disrupted copy of cj0309c-cj0310c, cj0423-cj0425,
cj1169c-cj1170c, or cj1173-cj1174 genes were con-
structed by insertional mutagenesis with antibiotic re-
sistance cassettes. The strategies are shown in Figure 1.
Primers used in the construction and complementation
of mutants are listed in Table 6. The chloramphenicol
(cat) and kanamycin (aphA-3) resistance cassettes were
PCR amplified using Ex-Taq (Takara Bio Inc.) from plas-
mids pUOA18 and pMW10 with cat and aphA3
primers, respectively, as described in a previous study
[38]. PCR products were digested with the appropriate
restriction enzymes (Table 6, Figure 1). The PCR prod-
ucts and a resistance cassette were ligated by T4 DNA
ligase (Promega, Madison, WI), cloned into suicide vec-
tor pUC19 (Invitrogen, Carlsbad, CA), and transformed
into competent E. coli DH5α (Invitrogen). Recombinant
clones with the intended mutation were confirmed by
PCR. Plasmids were extracted from DH5α and used to
transform wild-type NCTC 11168 by the standard
biphasic method for natural transformation [39].
Transformants were colony purified on MH plates with
supplemented antibiotics. Single colonies were selected
and confirmed by PCR. Mutations were complemented
by inserting the entire set of the wild-type copy of genes
between the structural genes of the ribosomal gene clus-
ter in the corresponding mutant strains as described
previously [37,40]. PCR amplification and sequencing
were performed on positive clones to confirm no muta-
tions occurred in the cloned sequences. All strains were
stored at −80°C for later use.
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Oxidative stress tests
To determine if the mutated genes affected the
susceptibility of C. jejuni to oxidative stress, wild-
type NCTC 11168 and mutant strains (KO39Q、KO
73Q、KO425Q、KOp50Q and DKO01Q) were com-
pared using two oxidative stress tests. In the first test,
inhibition of hydrogen peroxide (H2O2), cumene hydro-
peroxide and menadione on bacterial growth at 24 and
48 h on MH plate incubated microaerobically at 42°C were
measured by a disk diffusion method as described previ-
ously [41], with the following modification: The concentra-
tions of H2O2, cumene hydroperoxide and menadione used
were 1.5%, 2% and 45 mM, respectively. In the second test,
oxygen tolerance of wild-type and mutant strains was deter-
mined by measuring the viability/growth after incubation at
different oxygen levels (5% O2 or 18.5% O2) as described
previously [42] with modifications. Briefly, serial dilutions
of overnight cultures were spotted (5 μl) onto MH agar
plates and incubated at 37°C in incubators containing either
5% O2, 10% CO2, 85% N2 or 18.5% O2, 5% CO2,
76.5% N2 (Forma Scientific, model 3130). Growth was ex-
amined after 48 h of incubation. Experiments were repeated
three times independently.
Colonization and transmission experiments in chickens
To investigate if cj0309c-cj0310c and cj1173-cj1174,
which encode putative multidrug efflux systems, affect
Campylobacter adaptation in chickens, 3-day-old com-
mercial broiler chickens (Ross & Ross) were randomly
assigned to 4 groups (15 bird/group) and inoculated
with NCTC 11168 (group 1), KO39Q (Δcj0309c-cj0310c,
group 2), KO73Q (Δcj1173-cj1174, group 3), and
DKO01Q (Δcj0309c-cj0310 and Δcj1173-cj1174, group
4), respectively. Each bird received approximately 1x107
CFU of respective strain via oral gavage. The birds were
free of Campylobacter colonization as determined by
culturing of cloacal swabs prior to inoculation. Cecal
contents were collected from each bird at necropsy on 5,
10, and 15 DAI. The total number of Campylobacter in
each sample was determined by serial dilution and viable
counts on agar plates containing Campylobacter-specific
growth and selective supplements (Oxoid, United King-
dom). The samples from groups 2, 3, and 4 were also
plated on Campylobacter-selective agar plates containing
kanamycin or/and chloramphenicol as described earlier
to confirm the mutations. Campylobacter counts were
determined after 48 h incubation microaerobically at
42°C, and expressed as CFU/g feces for each bird at each
sampling point.
In addition to the colonization experiment described
above, co-mingling experiments were carried out to
determine the transmissibility of mutant strains from
Campylobacter-inoculated seeder birds to naive (non-
inoculated) birds. The strains used in this study in-
cluded the wild type strain NCTC 11168 (group 1),
DKO01Q (Δcj0309c-cj0310c and Δcj1173-cj1174,group
2), KOp50Q (Δcj1169c-cj1170c,group 3), and Comp50Q
(complemented KOp50Q strain, group 4). One-day-old
commercial broiler chickens (Ross & Ross) were ran-
domly assigned to four groups (n = 12 for groups inocu-
lated with KOp50Q or DKO01Q; n = 13 for the groups
with NCTC 11168 or Comp50Q), which were segregated
by cardboard pens in separate rooms. Three birds
(marked with a permanent marker) in each group were
randomly chosen and inoculated with a dose of 107 CFU
of respective strain via oral gavage at day 3 of age. After
inoculation, the inoculated birds were immediately
returned to the respective groups and allowed to comin-
gle with non-inoculated birds. Cloacal swabs were col-
lected from each bird at 3, 6, and 9 DAI for determining
the positivity (with Campylobacter) of the birds. Add-
itionally, the birds were necropsied at 9 and 12 DAI
(n = 6 or 7 for each time point) and the cecal contents
were collected for measuring the level of colonization. It
should be pointed out that in terms of time frame the
DAI were the same as days after initiation of comingling
as the co-mingling occurred immediately after inocula-
tion of the seeder birds. Cloacal swabs were streaked on
the selective agar media to determine Campylobacter
presence/absence. Cecal contents were serially diluted
and tested to quantify Campylobacter colonies as de-
scribed above.
The detection limit of the culture method used for the
chicken experiments was 100 CFU/g of feces. Cecal con-
tents contained less than 100 CFU/g Campylobacter col-
onies were considered negative and assigned a value of 0
for the purpose of statistical analysis. Significant differ-
ences (p < 0.05) in the colonization levels between
groups at each sampling time point were determined
using Student’s t test, Welch's t test to allow for non-
constant variation across treatment groups, and the
Wilcoxon rank-sum test to allow for non-normality [11].
All animals used in this study were handled in strict
accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National
Institutes of Health. The animal use protocol was ap-
proved by the Institutional Animal Care and Use Com-
mittee of Iowa State University (A3236-01). All efforts
were made to minimize suffering of animals.
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